Dr. Flynn is a Medical Oncology Consultant. He completed his PhD in antibody drug conjugate translational development at University College London and his specialist training at the Royal Marsden. He is a Principal Investigator on gynae-specific and tumour-agnostic targeted therapy, immunotherapy, and combination trials.